{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T01:32:38Z","timestamp":1649208758750},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1990,12,1]],"date-time":"1990-12-01T00:00:00Z","timestamp":660009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[1990,12]]},"DOI":"10.1097\/00000441-199012000-00003","type":"journal-article","created":{"date-parts":[[2006,9,28]],"date-time":"2006-09-28T04:46:21Z","timestamp":1159418781000},"page":"354-360","source":"Crossref","is-referenced-by-count":1,"title":["Chronic Therapy for Congestive Heart Failure with Benazepril HCl, a New Angiotensin Converting Enzyme Inhibitor"],"prefix":"10.1016","volume":"300","author":[{"given":"David M.","family":"Mirvis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerald","family":"Insel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Boland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Cinquegrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamal K.","family":"Ghali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley A.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Shanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"DeSilva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/00000441-199012000-00003_bb0010","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/0002-8703(88)90081-6","article-title":"ACE inhibition for the failing heart: Experience with captopril","volume":"115","author":"Faxon","year":"1988","journal-title":"Am Heart J"},{"key":"10.1097\/00000441-199012000-00003_bb0015","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJM198006193022501","article-title":"Sustained effectiveness of Converting enzyme Inhibition in patients with congestive heart failure","volume":"302","author":"Dzau","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-199012000-00003_bb0020","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative Northern Scandinavian Enalapril Survival Study","volume":"316","author":"CONSENSUS Trial Study Group","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-199012000-00003_bb0025","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/clpt.1989.34","article-title":"A multicenter study of the safety and efficacy of benazepril HCl, a long acting angiotensin Converting enzyme inhibitor, in patients with chronic congestive heart failure","volume":"45","author":"Insel","year":"1989","journal-title":"Clin Pharmacol Ther"},{"key":"10.1097\/00000441-199012000-00003_bb0030","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0002-8703(89)90765-5","article-title":"Pharmacokinetics of a new angiotensin-converting enzyme inhibitor, benazepril HCl, in special populations","volume":"117","author":"Kaiser","year":"1989","journal-title":"Am Heart J"},{"key":"10.1097\/00000441-199012000-00003_bb0035","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/0002-8703(89)90762-X","article-title":"Definition of the effective dose of the convertingenzyme inhibitor benazepril","volume":"117","author":"Whalen","year":"1989","journal-title":"Am Heart J"},{"key":"10.1097\/00000441-199012000-00003_bb0040","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.CIR.25.6.1015","article-title":"Hormones in the pathogenesis of congestive heart failure: Vasopressin, aldosterone and angiotensin II","volume":"25","author":"Laragh","year":"1962","journal-title":"Circulation"},{"key":"10.1097\/00000441-199012000-00003_bb0045","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.CIR.58.5.763","article-title":"Role of the reninangiotensin System in the chronic vasoconstriction of chronic congestive heart failure","volume":"58","author":"Curtiss","year":"1978","journal-title":"Circulation"},{"key":"10.1097\/00000441-199012000-00003_bb0050","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/0002-8703(82)90045-X","article-title":"Determinants of acute and long-term response to Converting enzyme inhibitors in congestive heart failure","volume":"104","author":"Levine","year":"1982","journal-title":"Am Heart J"},{"key":"10.1097\/00000441-199012000-00003_bb0055","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/0002-9149(82)90351-4","article-title":"Angiotensin Converting enzyme inhibitors and prostaglandins","volume":"49","author":"Swartz","year":"1982","journal-title":"Am J Cardiol"},{"key":"10.1097\/00000441-199012000-00003_bb0060","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2362.1981.tb02012.x","article-title":"Reduction of plasma and urinary vasopressin during treatment of severe hypertension with captopril","volume":"11","author":"Thibonnier","year":"1981","journal-title":"Eur J Clin Invest"},{"issue":"Suppl I","key":"10.1097\/00000441-199012000-00003_bb0065","first-page":"I4","article-title":"Circulating versus local renin angiotensin System in cardiovascular homeostasis","volume":"77","author":"Dzau","year":"1988","journal-title":"Circulation"},{"key":"10.1097\/00000441-199012000-00003_bb0070","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/01.CIR.61.5.931","article-title":"Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin Converting enzyme inhibitor","volume":"61","author":"Ader","year":"1980","journal-title":"Circulation"},{"key":"10.1097\/00000441-199012000-00003_bb0075","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/0002-8703(82)90048-5","article-title":"Captopril pharmacokinetics and acute hemodynamic and humoral response in patients with severe congestive heart failure","volume":"104","author":"Cody","year":"1982","journal-title":"Am Heart J"},{"key":"10.1097\/00000441-199012000-00003_bb0080","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/hrt.54.3.305","article-title":"Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones and metabolic state","volume":"54","author":"Cleland","year":"1985","journal-title":"Br Heart J"},{"key":"10.1097\/00000441-199012000-00003_bb0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0002-8703(86)90689-7","article-title":"Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failure","volume":"112","author":"Dickstein","year":"1986","journal-title":"Am Heart J"},{"key":"10.1097\/00000441-199012000-00003_bb0090","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0735-1097(83)80316-7","article-title":"A placebo controlled trial of captopril in refractory chronic congestive heart failure","volume":"2","author":"Captopril Multicenter Research Group","year":"1983","journal-title":"J Am Coli Cardiol"},{"key":"10.1097\/00000441-199012000-00003_bb0095","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/0735-1097(89)90294-5","article-title":"Short-and long-acting angiotensin Converting enzyme inhibitors: A randomized trial of lisinopril versus captopril in the treatment of congestive heart failure","volume":"13","author":"Giles","year":"1989","journal-title":"J Am Coli Cardiol"},{"key":"10.1097\/00000441-199012000-00003_bb0100","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/01.CIR.59.3.531","article-title":"Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure","volume":"59","author":"Packer","year":"1979","journal-title":"Circulation"},{"key":"10.1097\/00000441-199012000-00003_bb0105","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0002-8703(82)90231-9","article-title":"Hydralazine in the long-term treatment of chronic heart failure: Lack of difference from placebo","volume":"104","author":"Franciosa","year":"1982","journal-title":"Am Heart J"},{"key":"10.1097\/00000441-199012000-00003_bb0110","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/01.CIR.69.3.548","article-title":"Hemodynamic and clinical response to enalapril, a long acting Converting enzyme inhibitor in patients with congestive heart failure","volume":"69","author":"Levine","year":"1984","journal-title":"Circulation"},{"key":"10.1097\/00000441-199012000-00003_bb0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-90-1-19","article-title":"Oral angiotensin Converting enzyme inhibitor in long-term treatment of hypertensive patients","volume":"90","author":"Brunner","year":"1979","journal-title":"Ann Int Med"},{"key":"10.1097\/00000441-199012000-00003_bb0120","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/clpt.1988.85","article-title":"Discrepancy between first-dose Converting enzyme inhibition at rest and subsequent inhibition during exercise","volume":"43","author":"Kirlin","year":"1988","journal-title":"Clin Pharmacol Ther"},{"key":"10.1097\/00000441-199012000-00003_bb0125","first-page":"131","article-title":"Renal actions of the new angiotensin-converting inhibitor benazepril hydrochloride","volume":"296","author":"Levens","year":"1988","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1097\/00000441-199012000-00003_bb0130","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM198610023151402","article-title":"Comparison of captopril and enalapril in patients with severe chronic heart failure","volume":"315","author":"Packer","year":"1986","journal-title":"New Engl J Med"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915359954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915359954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T16:56:04Z","timestamp":1547312164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915359954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1990,12]]}},"alternative-id":["S0002962915359954"],"URL":"https:\/\/doi.org\/10.1097\/00000441-199012000-00003","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[1990,12]]}}}